Grants for Unrestricted - Science and Technology

The Arts Council of Southwestern Indiana (ARTSWIN) recognizes individuals, groups, businesses, projects, and institutions that have made significant contributions to the arts in Southwestern Indiana. This grant program, specifically focused on various awards, aligns with ARTSWIN's mission to support and promote the arts within the community. The awards aim to celebrate artistic excellence, long-standing commitment to the arts, and the positive impact of arts activities on the City of Evansville and Vanderburgh County. The target beneficiaries for these awards include individual artists (visual, performing, film, literary), young artists (rising high school juniors or seniors), arts educators, and community projects that utilize the arts for advancement. The impact goals are to acknowledge and encourage artistic talent, foster community engagement through the arts, and recognize the vital role the arts play in community, economic development, and quality of life. The program prioritizes and focuses on several categories: the Mayor’s Art Award for exceptional, long-standing impact; Visual Arts Award for outstanding visual artists; Performing Arts Award for exceptional performing artists; Young Artist Award for promising high school students; Arts Educator Award for influential educators; and the Arts Project Award for projects advancing community goals. A key focus is on current residents of Vanderburgh County for the Mayor's Art Award, and generally on those whose arts activities have had a significant impact on the City of Evansville or Southwestern Indiana. The expected outcomes and measurable results include the public recognition of significant contributions to the arts, the encouragement of emerging talent, and the celebration of arts-led community development initiatives. While specific quantitative measures are not detailed, the prestige of the awards and the public recognition serve as a form of measurable impact, elevating the profile of the arts and inspiring further artistic endeavors within the region. The repeated emphasis on impact within the community underscores ARTSWIN's strategic priority to integrate the arts as a core component of regional identity and development.

This funding opportunity is designed to support a wide range of research and technology projects related to space and Earth sciences, encouraging proposals from various organizations, including government, private, and non-profit entities.

This funding opportunity is designed for research institutions and organizations affiliated with the Great Rivers Cooperative Ecosystem Studies Unit to study floodplain forest canopy loss and regeneration in the Upper Mississippi River System, utilizing innovative survey methods.

This program provides funding to research teams, patient advocacy groups, and healthcare organizations to develop innovative AI and machine learning solutions that improve the diagnosis of rare diseases, ultimately reducing diagnostic delays and enhancing patient care.

This funding opportunity is designed for research institutions and organizations affiliated with the Chesapeake Watershed Cooperative Ecosystem Studies Unit to develop advanced soil moisture mapping techniques using drone technology.

This funding opportunity is designed for organizations affiliated with the Great Rivers Cooperative Ecosystem Studies Unit to develop a long-term monitoring program for floodplain vegetation in the Upper Mississippi River System.

The ADAPT Program, initiated by the Advanced Research Projects Agency for Health (ARPA-H), aims to transform cancer care through innovative research focused on developing adaptive strategies for treating the evolution of cancer. This program seeks to create a dynamic cancer treatment platform capable of detecting tumor changes, updating treatment plans accordingly, and evaluating these plans through a novel clinical trial design. The goal is to match each patient’s evolving cancer with the most effective therapy, thereby revolutionizing cancer care by integrating new science and medical approaches to improve survival rates for patients with metastatic cancer.

This grant provides funding for collaborative research teams to advance the understanding and treatment of eye injuries and visual dysfunction caused by military-related exposures.

This funding opportunity supports clinical trials that aim to improve the treatment and management of health conditions relevant to military personnel, targeting researchers and organizations involved in medical research.

This grant seeks an independent contractor to evaluate New York's Tobacco Control Program, focusing on reducing tobacco use and its health impacts, particularly among marginalized communities.

The NFRP Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to NF research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinicians firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.

The FY24 LCRP Translational Research Award mechanism supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. Observations that drive a research idea may originate from a laboratory discovery, population-based studies, or a clinicians firsthand knowledge of patient care. The ultimate goal of translational research is to move a concept or observation forward into clinical application. However, Principal Investigators (PIs) should not view translational research as a one-way continuum from bench to bedside but can include a reciprocal flow of ideas and information between basic science and clinical science (bench to bedside and/or bedside to bench). Research applications only in the area of mesothelioma will not be accepted. This mechanism is intended to fund a broad range of translational studies with two different funding levels. The following are general examples, although not all-inclusive, of the type of research projects that would be appropriate to propose under the current program announcement:Funding Level 1: Advanced preclinical studies aimed at translating results from animal studies to applications with human samples/cohorts (The Translational Research Award is not intended to support initial mechanistic studies of a new target.) Late-stage preclinical work leading to/preparing for a clinical trial, e.g., Investigational New Drug (IND) application submission Correlative studies that are associated with an open/ongoing or completed clinical trial, e.g., projects that utilize biospecimens from clinical trials to improve clinical management of lung cancer and/or define new areas of research Projects that develop endpoints for clinical trialsFunding Level 2 Pilot clinical trials where limited clinical testing (e.g., small sample size) of a novel intervention is necessary to inform the next step in the continuum of translational researchPreliminary lung cancer relevant data to support the feasibility of the research hypotheses and research approaches are required.

This funding opportunity is designed for research institutions within the Rocky Mountain Cooperative Ecosystem Studies Unit network to study and improve the immune health of endangered bumble bee species, focusing on strategies to combat the pathogen threatening their populations.

The FY24 HRRP FRA mechanism is intended to support promising research that accelerates drug discovery and therapeutic development for hearing restoration after military-relevant auditory system injury. Applicants are encouraged to leverage resources and expertise at the National Center for Advancing Translational Sciences (NCATS) to improve efficiency and accelerate the translational process. A list of NCATS programs and resources supporting preclinical innovation can be found at https://ncats.nih.gov/preclinical. Applications from investigators within the military Services and applications involving multidisciplinary collaborations among academia, industry, the military Services, the VA, and other federal government agencies are highly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research.

This funding opportunity is designed for research partners in the Pacific Northwest to study the impact of tire-derived chemicals on coho salmon health and survival, particularly in relation to urban runoff pollution.

This funding opportunity is designed to support projects that develop and test new technologies for large-scale carbon storage, targeting organizations and researchers focused on advancing carbon capture and storage solutions to help achieve U.S. decarbonization goals.

This grant provides funding for institutions affiliated with the Cooperative Ecosystem Studies Units to conduct a comprehensive recreational boating survey at Broken Bow Lake in Oklahoma, aimed at improving management and planning for recreational activities.

This program provides funding to innovators developing non-invasive tear-based diagnostic technologies for continuous health monitoring and personalized treatment, initially targeting Dry Eye Disease.

This funding opportunity is designed for partners affiliated with the Colorado Plateau Cooperative Ecosystem Studies Unit to develop advanced camera-based water monitoring technology for the U.S. Geological Survey's national network.

The PRCRP is seeking to advance cancer research through development of early-career investigators. Under this award mechanism, the early-career investigator is considered the Principal Investigator (PI), and the application should focus on the PIs research and career development. Preliminary data are not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated. This award supports impactful research projects with an emphasis on discovery. The CDA-SO supports an independent, highly accomplished early-career investigator (referred to as a Scholar) to conduct impactful research under the guidance of an experienced cancer researcher (i.e., Career Guide). Scholars are required to participate in the unique, interactive Virtual Cancer Center (VCC) focused on fostering the next generation of cancer researchers. The overarching goal of the VCC is to develop successful, highly productive Scholars in a collaborative research and career developmental environment. The VCC will give Scholars opportunities to operate in a collegial, highly dynamic, and cutting edge research organization to lead cancer research to a new frontier. It is the intention that, through the VCC, collaborations will foster new growth to ensure the research advancements across different cancers. The VCC directorship is awarded through a separate mechanism, the Virtual Cancer Center Directors Award (VCCDA). The VCCDA calls for two established investigators (Director and Deputy Director) to provide intensive mentoring, national networking, collaborations, and a peer group for Scholars. In addition to their Career Guide, Scholars are required to interact with the VCC Director, Deputy Director, and fellow Scholars to include required attendance at in-person meeting with VCC Members annually. The intention of the Scholar Option is to support highly accomplished investigators toward the goal of leadership in cancer. The critical components of the Career Development Award: Principal Investigator: The PI must be an early-career researcher or physician-scientist within 7 years after completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training, or on family medical leave). Time spent as a postdoctoral fellow is not excluded. Postdoctoral fellows are not eligible for this award mechanism. The PIs record of accomplishments and the proposed research will be evaluated regarding their potential for contributing to at least one of the FY24 PRCRP Topic Areas. The Scholar must be in a tenure-track position or equivalent position. The Scholar must demonstrate significant accomplishments, including first-author publications, extramural funding (beyond nominal), and show excellence in cancer research as supported by letters of recommendation. The Scholar must have independent laboratory space separate from the Career Guides laboratory or other mentors laboratory. For more information on the eligibility criteria for the Virtual Cancer Center Scholar Option, refer to Section II.C.1. Career Guide: The Scholar must designate a Career Guide. The Career Guide must be an experienced cancer researcher, as demonstrated by a strong record of funding and publications. In addition, the Career Guide must demonstrate a commitment to advancing the PIs career in cancer research and be committed to fully participating in the VCC and potentially serving on the VCCs Advisory Board as requested by VCC Leadership. Career Development Plan: A career development plan is required and should be prepared with appropriate guidance from the Career Guide. The career development plan should include a clearly articulated strategy for acquiring the necessary skills, competence, further independence, and expertise to advance their career at the forefront of cancer research in at least one of the FY24 PRCRP Topic Areas. Milestones: The Scholar must show career milestones and pathways toward achieving the milestones. The Scholar should demonstrate clear commitment to at least one of the FY24 PRCRP Topic Areas through a career development plan designed to enhance further networking and collaboration. Impact: The applicant must articulate the potential impact the proposed work will have on cancer research and/or patient care. Impactful research will accelerate the movement of promising ideas in cancer research into clinical applications.